Rivastigmine Alleviates Experimentally Induced Colitis in Mice and Rats by Acting at Central and Peripheral Sites to Modulate Immune Responses

PLoS ONE

Volumn 8, Issue 2, 2013, Pages

  Shifrin, Helena ^a   Nadler Milbauer, Mirela ^a   Shoham, Shai ^a   Weinstock, Marta ^a  

^a HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCHOLINE; BUNGAROTOXIN RECEPTOR; CARBACHOL; CD11B ANTIGEN; CHOLINESTERASE; DEXTRAN SULFATE; INTERLEUKIN 1BETA; INTERLEUKIN 6; MYELOPEROXIDASE; NITRIC OXIDE; RIVASTIGMINE; SCOPOLAMINE BROMIDE; TUMOR NECROSIS FACTOR ALPHA;

ALPHA ADRENERGIC RECEPTOR BLOCKING; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN EXPRESSION; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CELL INFILTRATION; COLITIS; COLON INJURY; CONTROLLED STUDY; CROHN DISEASE; CROHN DISEASE ACTIVITY INDEX; CYTOKINE RELEASE; ENZYME ACTIVITY; ENZYME INHIBITION; IMMUNOMODULATION; INHIBITION KINETICS; MALE; MOUSE; NONHUMAN; RAT; ULCERATIVE COLITIS;

ANIMALS; ANTI-INFLAMMATORY AGENTS; ANTIGENS, CD11B; BRAIN; CELL LINE; CHOLINESTERASES; COLITIS, ULCERATIVE; COLON; CROHN DISEASE; DEXTRAN SULFATE; DINITROFLUOROBENZENE; DISEASE MODELS, ANIMAL; LIPOPOLYSACCHARIDES; MACROPHAGES, PERITONEAL; MALE; MICE; NITRIC OXIDE; PEROXIDASE; PHENYLCARBAMATES; RATS; THIOBARBITURIC ACID REACTIVE SUBSTANCES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84874562452     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0057668     Document Type: Article

References (37)

1. Baumgart DC, Sandborn WJ, (2007) Inflammatory bowel disease: clinical aspects and established and evolving therapies. Lancet 369: 1641-1657.
2. Podolsky DK, (2002) Inflammatory bowel disease. N Engl J Med 347: 417-429.
3. Desreumaux P, Brandt E, Gambiez L, Emilie D, Geboes K, et al. (1997) Distinct cytokine patterns in early and chronic ileal lesions of Crohn's disease. Gastroenterology 113: 118-126.
4. Groux H, O'Garra A, Bigler M, Rouleau M, Antonenko S, et al. (1997) A CD4+ T-cell subset inhibits antigen-specific T-cell responses and prevents colitis. Nature 389: 737-742.
5. Hibi T, Ogata H, Sakuraba A, (2002) Animal models of inflammatory bowel disease. J Gastroenterol 37: 409-417.
6. Wirtz S, Neurath MF, (2007) Mouse models of inflammatory bowel disease. Adv Drug Deliv Rev 59: 1073-1083.
7. Elson CO, Sartor RB, Tennyson GS, Riddell RH, (1995) Experimental models of inflammatory bowel disease. Gastroenterology 109: 1344-1367.
8. Ghia JE, Blennerhassett P, Kumar-Ondiveeran H, Verdu EF, Collins SM, (2006) The vagus nerve: a tonic inhibitory influence associated with inflammatory bowel disease in a murine model. Gastroenterology 131: 1122-1130.
9. Borovikova LV, Ivanova S, Zhang M, Yang H, Botchkina GI, et al. (2000) Vagus nerve stimulation attenuates the systemic inflammatory response to endotoxin. Nature 405: 458-462.
10. van Westerloo DJ, Giebelen IA, Florquin S, Daalhuisen J, Bruno MJ, et al. (2005) The cholinergic anti-inflammatory pathway regulates the host response during septic peritonitis. J Infect Dis 191: 2138-2148.
11. Kawashima K, Yoshikawa K, Fujii YX, Moriwaki Y, Misawa H, (2007) Expression and function of genes encoding cholinergic components in murine immune cells. Life Sci 80: 2314-2319.
12. Tracey KJ, (2002) The inflammatory reflex. Nature 420: 853-859.
13. Pavlov VA, Wang H, Czura CJ, Friedman SG, Tracey KJ, (2003) The cholinergic anti-inflammatory pathway: a missing link in neuroimmunomodulation. Mol Med 9: 125-134.
14. Wang H, M Y, Ochani M, Amella C, Tanovic M, et al. (2003) Nicotinic acetylcholine receptor alpha7 subunit is an essential regulator of inflammation. Nature 421: 384-388.
15. Kawashima K, Fujii T, (2003) The lymphocytic cholinergic system and its biological function. Life Sci 72: 2101-2109.
16. Su X, Matthay MA, Malik AB, (2010) Requisite role of the cholinergic alpha7 nicotinic acetylcholine receptor pathway in suppressing Gram-negative sepsis-induced acute lung inflammatory injury. J Immunol 184: 401-410.
17. Yoshikawa H, Kurokawa M, Ozaki N, Nara K, Atou K, et al. (2006) Nicotine inhibits the production of proinflammatory mediators in human monocytes by suppression of I-kappaB phosphorylation and nuclear factor-kappaB transcriptional activity through nicotinic acetylcholine receptor alpha7. Clin Exp Immunol 146 116-23: 116-123.
18. Snoek SA, Verstege MI, van der Zanden EP, Deeks N, Bulmer DC, et al. (2010) Selective alpha7 nicotinic acetylcholine receptor agonists worsen disease in experimental colitis. Br J Pharmacol 160: 322-333.
19. Nizri E, Irony-Tur-Sinai M, Faranesh N, Lavon I, Lavi E, et al. (2008) Suppression of neuroinflammation and immunomodulation by the acetylcholinesterase inhibitor rivastigmine. J Neuroimmunol 203: 12-22.
20. Bredt DS, Snyder SH, (1994) Nitric oxide: a physiologic messenger molecule. Annu Rev Biochem 63: 175-195.
21. Wang RH, Bejar C, Weinstock M, (2000) Gender differences in the effect of rivastigmine on brain cholinesterase activity and cognitive function in rats. Neuropharmacology 39: 497-506.
22. Ellman GL, Courtney KD, Andres V Jr, Feather-Stone RM, (1961) A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem Pharmacol 7: 88-95.
23. Kullmann F, Messmann H, Alt M, Gross V, Bocker T, et al. (2001) Clinical and histopathological features of dextran sulfate sodium induced acute and chronic colitis associated with dysplasia in rats. Int J Colorectal Dis 16: 238-246.
24. Bradley PP, Christensen RD, Rothstein G, (1982) Cellular and extracellular myeloperoxidase in pyogenic inflammation. Blood 60: 618-622.
25. Jubeh TT, Nadler-Milbauer M, Barenholz Y, Rubinstein A, (2006) Local treatment of experimental colitis in the rat by negatively charged liposomes of catalase, TMN and SOD. J Drug Target 14: 155-163.
26. Dmitrieva NA, Strang CE, Keyser KT, (2007) Expression of alpha 7 nicotinic acethylcholine receptors by bipolar, amacrine and ganglion cells of the rabbit retina. J Histolchem Cytochem 55: 461-476.
27. Yang XD, Ai W, Asfaha S, Bhagat G, Friedman RA, et al. (2011) Histamine deficiency promotes inflammation-associated carcinogenesis through reduced myeloid maturation and accumulation of CD11b+Ly6G+ immature myeloid cells. Nat Med Jan 17: 87-95.
28. Pavlov VA, Parrish WR, Rosas-Ballina M, Ochani M, Puerta M, et al. (2009) Brain acetylcholinesterase activity controls systemic cytokine levels through the cholinergic anti-inflammatory pathway. Brain Behav Immun 23: 41-45.
29. Saeed RW, Varma S, Peng-Nemeroff T, Sherry B, Balakhaneh D, et al. (2005) Cholinergic stimulation blocks endothelial cell activation and leukocyte recruitment during inflammation. J Exp Med 201: 1113-1123.
30. Wang H, Liao H, Ochani M, Justiniani M, Lin X, et al. (2004) Cholinergic agonists inhibit HMGB1 release and improve survival in experimental sepsis. Nat Med 10: 1216-1221.
31. de Jonge WJ, van der Zanden EP, The FO, Bijlsma MF, van Westerloo DJ, et al. (2005) Stimulation of the vagus nerve attenuates macrophage activation by activating the Jak2-STAT3 signaling pathway. Nat Immunol 6: 844-851.
32. Huston JM, Ochani M, Rosas-Ballina M, Liao H, Ochani K, et al. (2006) Splenectomy inactivates the cholinergic antiinflammatory pathway during lethal endotoxemia and polymicrobial sepsis. J Exp Med 203: 1623-1628.
33. Vida G, Pena G, Deitch EA, Ulloa L, (2011) Alpha 7-cholinergic receptor mediates vagal induction of splenic norepinephrine. J Immunol 186: 4340-4346.
34. Barnes CA, Meltzer J, Houston F, Orr G, McGann K, et al. (2000) Chronic treatment of old rats with donepezil or galantamine: effects on memory, hippocampal plasticity and nicotinic receptors. Neuroscience 99: 17-23.
35. Pavlov VA, Ochani M, Gallowitsch-Puerta M, Ochani K, Huston JM, et al. (2006) Central muscarinic cholinergic regulation of the systemic inflammatory response during endotoxemia. Proc Natl Acad Sci U S A 103: 5219-5223.
36. Miceli PC, Jacobson K, (2003) Cholinergic pathways modulate experimental dinitrobenzene sulfonic acid colitis in rats. Auton Neurosci 105: 16-24.
37. Bai A, Guo Y, Lu N, (2007) The effect of the cholinergic anti-inflammatory pathway on experimental colitis. Scand J Immunol 66: 538-545.